Why the study?
Cardiovascular diseases pose formidable challenges as the global population ages, and sarcopenia is intricately linked to cardiovascular health.
This review underscores the intertwined nature of sarcopenia and cardiovascular diseases in the elderly, advocating for holistic management strategies that address both muscle and cardiovascular health.
Supports exercise capacity and sarcopenia assessment in elderly CVD patients; leaves open prospective trials on targeted interventions.
As the global population ages, age-related diseases, particularly cardiovascular ailments, pose formidable challenges to healthcare systems worldwide. This review highlights the importance of exercise in both the prevention and rehabilitation of cardiovascular disorders, underscoring the pronounced correlation between diminished exercise capacity in the elderly and heightened disease susceptibility. Moreover, sarcopenia, defined by reduced muscle mass and function, is intricately linked to cardiovascular health. The article reviews recent studies on the pathophysiology, interactions, mechanisms, clinical presentations, diagnostic criteria, and treatments of sarcopenia and cardiovascular diseases, with the objective of fostering a nuanced comprehension of these maladies.
No takes yet. Share an insight, caveat, or question.
Jia et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: